Cargando…
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease
[Image: see text] Nowadays, nutraceuticals are being incorporated into functional foods or used as supplements with nonpharmacological approaches in the prevention and management of several illnesses, including age-related conditions and chronic neurodegenerative diseases. Nutraceuticals are apt for...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552500/ https://www.ncbi.nlm.nih.gov/pubmed/37810693 http://dx.doi.org/10.1021/acsomega.3c04855 |
_version_ | 1785115976569716736 |
---|---|
author | Reza-Zaldívar, Edwin E. Jacobo-Velázquez, Daniel A. |
author_facet | Reza-Zaldívar, Edwin E. Jacobo-Velázquez, Daniel A. |
author_sort | Reza-Zaldívar, Edwin E. |
collection | PubMed |
description | [Image: see text] Nowadays, nutraceuticals are being incorporated into functional foods or used as supplements with nonpharmacological approaches in the prevention and management of several illnesses, including age-related conditions and chronic neurodegenerative diseases. Nutraceuticals are apt for preventing and treating such disorders because of their nontoxic, non-habit-forming, and efficient bioactivities for promoting neurological well-being due to their ability to influence cellular processes such as neurogenesis, synaptogenesis, synaptic transmission, neuro-inflammation, oxidative stress, cell death modulation, and neuronal survival. The capacity of nutraceuticals to modify all of these processes reveals the potential to develop food-based strategies to aid brain development and enhance brain function, prevent and ameliorate neurodegeneration, and possibly reverse the cognitive impairment observed in Alzheimer’s disease, the most predominant form of dementia in the elderly. The current review summarizes the experimental evidence of the neuroprotective capacity of nutraceuticals against Alzheimer’s disease, describing their mechanisms of action and the in vitro and in vivo models applied to evaluate their neuroprotective potential. |
format | Online Article Text |
id | pubmed-10552500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-105525002023-10-06 Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease Reza-Zaldívar, Edwin E. Jacobo-Velázquez, Daniel A. ACS Omega [Image: see text] Nowadays, nutraceuticals are being incorporated into functional foods or used as supplements with nonpharmacological approaches in the prevention and management of several illnesses, including age-related conditions and chronic neurodegenerative diseases. Nutraceuticals are apt for preventing and treating such disorders because of their nontoxic, non-habit-forming, and efficient bioactivities for promoting neurological well-being due to their ability to influence cellular processes such as neurogenesis, synaptogenesis, synaptic transmission, neuro-inflammation, oxidative stress, cell death modulation, and neuronal survival. The capacity of nutraceuticals to modify all of these processes reveals the potential to develop food-based strategies to aid brain development and enhance brain function, prevent and ameliorate neurodegeneration, and possibly reverse the cognitive impairment observed in Alzheimer’s disease, the most predominant form of dementia in the elderly. The current review summarizes the experimental evidence of the neuroprotective capacity of nutraceuticals against Alzheimer’s disease, describing their mechanisms of action and the in vitro and in vivo models applied to evaluate their neuroprotective potential. American Chemical Society 2023-09-20 /pmc/articles/PMC10552500/ /pubmed/37810693 http://dx.doi.org/10.1021/acsomega.3c04855 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Reza-Zaldívar, Edwin E. Jacobo-Velázquez, Daniel A. Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease |
title | Comprehensive Review
of Nutraceuticals against Cognitive
Decline Associated with Alzheimer’s Disease |
title_full | Comprehensive Review
of Nutraceuticals against Cognitive
Decline Associated with Alzheimer’s Disease |
title_fullStr | Comprehensive Review
of Nutraceuticals against Cognitive
Decline Associated with Alzheimer’s Disease |
title_full_unstemmed | Comprehensive Review
of Nutraceuticals against Cognitive
Decline Associated with Alzheimer’s Disease |
title_short | Comprehensive Review
of Nutraceuticals against Cognitive
Decline Associated with Alzheimer’s Disease |
title_sort | comprehensive review
of nutraceuticals against cognitive
decline associated with alzheimer’s disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552500/ https://www.ncbi.nlm.nih.gov/pubmed/37810693 http://dx.doi.org/10.1021/acsomega.3c04855 |
work_keys_str_mv | AT rezazaldivaredwine comprehensivereviewofnutraceuticalsagainstcognitivedeclineassociatedwithalzheimersdisease AT jacobovelazquezdaniela comprehensivereviewofnutraceuticalsagainstcognitivedeclineassociatedwithalzheimersdisease |